glp 1 black box warning Ozempic carries an FDA for medullary thyroid carcinoma. Over 1,800 lawsuits are consolidated in federal MDL litigation with >$2 billion projected liability — primarily for gastroparesis, intestinal blockage, gallbladder FDA Ozempic Warning | Ozempic

I do not know of anyone in the area

At a clinical level, responsible peptide therapy includes: Baseline laboratory testing Glucose monitoring Hormonal panel evaluation Ongoing dose adjustments Safety follow-up If you are exploring IGF-1 LR3 dosage or other peptide therapy protocols, consultation with a qualified provider ensures that treatment is aligned with your physiology rather than generalized internet protocols

(2022) 7:eabm6931

This means that under this classification these products have to be subjected to rigorous phase 1 and phase 2 clinical trials to first prove their safety and then their effectiveness